載入...
Protection from chemotherapy- and antibiotic-mediated dysbiosis of the gut microbiota by a probiotic with digestive enzymes supplement
There are numerous downstream consequences of marketed drugs like antineoplastic agents on the gut microbiome, an effect that is suggested to contribute to adverse event profiles and may also influence drug responses. In cancer, progress is needed toward modulation of the host microbiome to prevent...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6089397/ https://ncbi.nlm.nih.gov/pubmed/30112118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25778 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|